“ DATS and methotrexate ( MTX ) decreased the ratio of drug-resistant human osteosarcoma cells positive for CD133 (a tumor stem cell marker).”
“To the best of our knowledge, this is the first evidence that DATS can reverse drug resistance and lower the ratio of CD133+ cells in human osteosarcoma cells in conjunction with MTX.”